SEC Settlement Fails to Lift Coinbase as Stock Tumbles Nearly 5%

A FOIA settlement with the SEC couldn't stop Coinbase from sliding nearly 5% in Tuesday trading. Meanwhile, the Clarity Act faces a make-or-break Senate vote, with ethics provisions still dividing the parties.

Coinbase stock price chart showing decline after SEC settlement news
The SEC settlement failed to reverse Coinbase's slide, with shares down nearly 5% in afternoon trading as regulatory uncertainty persists.

The SEC settled a FOIA lawsuit with Coinbase over lost message records, but the news failed to lift the stock. As of 3:30 PM ET on July 22, Coinbase (COIN) traded at $167.15, down 4.95% from the prior close of $175.85.

  • Settlement: The SEC and Coinbase resolved a FOIA lawsuit alleging the company lost records, as reported by the WSJ opinion page.[Reuters]
  • Price action: Coinbase opened at $172.985, hit an intraday high of $174.958, and a low of $166.04.[Finnhub]
  • Regulatory bill progress: The Clarity Act, aimed at regulating crypto markets, faces a critical Senate vote. The White House has agreed to an ethics provision barring federal officials from issuing digital assets, but bipartisan divisions remain.[The Hill]
  • Ethics provision controversy: Democratic senators insist on strong ethics rules to prevent elected officials, including the president, from profiting off crypto. The DOJ would enforce the ban.[CNBC]
  • Industry impact: The bill's illicit-finance provisions require exchanges and intermediaries to comply with the Bank Secrecy Act and establish anti-money laundering programs, while offering civil immunity for companies that voluntarily freeze suspicious transactions.[The Hill]

The SEC has settled a FOIA lawsuit with Coinbase (COIN) over lost message records. Yet the legal resolution did little to stem the stock's slide in Tuesday trading. As of 3:30 PM ET on July 22, Coinbase shares traded at $167.15, down 4.95% — or $8.70 — from the prior close of $175.85. The stock opened at $172.985, hit an intraday high of $174.958, and a low of $166.04.

Settlement Details and Market Reaction

According to Reuters, the SEC and Coinbase settled a FOIA lawsuit alleging the company lost relevant communications. The news was first reported by the WSJ opinion page.[Reuters] While settlements typically remove uncertainty, the market's reaction to Coinbase was decidedly negative. With the broader crypto market and regulatory direction still unclear, investors appeared cautious about a single legal resolution. The stock touched an intraday low of $166.04, reflecting significant selling pressure.

Clarity Act Legislation Enters Critical Phase

As Coinbase navigates regulatory headwinds, the battle over the Clarity Act — a crypto market structure bill — is heating up in Congress. According to The Hill, the White House has agreed to include a sweeping ethics provision that would bar all federal officials from offering or issuing digital assets, with enforcement by the DOJ.[The Hill] A White House official said: "The administration is committed to working with Congress to advance the Clarity Act and has agreed to the most comprehensive ethics provision in history."

The concession is seen as a key move to win Democratic support. Democrats have long pushed for provisions limiting elected officials from profiting off crypto, especially amid concerns about President Trump and his family's digital asset ventures. Senate Majority Leader John Thune sounded uncertain about the bill's prospects, telling reporters: "It depends on whether Democrats can come together and give us the votes to move forward… Today, I think there's a good chance they'll find some consensus and get enough votes."[The Hill]

Core Provisions and Industry Impact

The Clarity Act goes beyond ethics, imposing stricter oversight on crypto markets. According to CNBC, the bill would bar federal officials, including the president, from issuing or sponsoring cryptocurrencies.[CNBC] However, Democrats argue the DOJ should not be the enforcing agency.

The bill's illicit-finance provisions are also drawing attention. Montana Attorney General Austin Knudsen, writing in The Hill, argued the bill gives law enforcement the tools needed to crack down on illegal activity in decentralized finance (DeFi). He cited an example where a major digital asset company's compliance team flagged over $200 million in stablecoins heading to North Korea, but the company couldn't act due to the risk of civil lawsuits under current law.[The Hill]

The Clarity Act would require exchanges and intermediaries to comply with the Bank Secrecy Act and establish anti-money laundering programs that exceed current money-services business standards. It would also grant civil immunity to digital asset companies and stablecoin issuers that voluntarily freeze suspicious transactions or comply with law enforcement requests. Knudsen believes this provision gives companies the legal confidence to act, preventing funds from reaching adversaries.

Bipartisan Battle and Legislative Outlook

While the Clarity Act has advanced through both the Senate Banking and Agriculture Committees, its fate on the Senate floor remains uncertain. According to Forbes, the bill's path has been rocky. In January, Coinbase CEO Brian Armstrong abruptly derailed a bipartisan agreement and a Banking Committee vote.[Forbes]

Senators Angela Alsobrooks and Thom Tillis later reached a bipartisan compromise on yield issues, allowing the committee to advance the bill in May. But ethics provisions quickly became a key Democratic demand. Senators Alsobrooks and Ruben Gallego have made their final votes contingent on the ethics language. Meanwhile, law enforcement opposition to developer protections and big-bank lobbying on yield issues have further complicated the final version. If the Senate can't pass the bill in the next three weeks, experts say it's unlikely to become law before the midterm elections.[The Hill]

This content is for informational purposes only and does not constitute investment advice, trading advice, or any guarantee of returns.

Keep Reading

Novo Nordisk Sues Eli Lilly Over ‘Misleading’ Weight-Loss Ads; LLY Slips 1% After Hours

Novo Nordisk Sues Eli Lilly Over ‘Misleading’ Weight-Loss Ads; LLY Slips 1% After Hours

The two titans of the global weight-loss drug market — Novo Nordisk and Eli Lilly — are escalating their battle from market share to the courtroom. On July 21, Novo Nordisk filed a federal lawsuit in the U.S., accusing Lilly of running national ads for its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro that use “outdated” clinical trial data to mislead consumers through unfair comparisons, disparaging the efficacy of Novo’s own Wegovy and Ozempic. Lilly has forcefully denied the claims, saying its ads are

Read full story →

Stay ahead of the market — never miss a deep dive

Follow OurAlpha for AI-driven US equity research and market insight, every day.